Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2026 年第 1 季持倉
持倉截至 2026/3/31，2026/5/15 申報。只含多頭部位，變化是跟 2025 年第 4 季比股數。
- 持股檔數
- 62
- 較 2025 年第 4 季 +9
- 總值
- $48.5 億
- 較 2025 年第 4 季 +$4.62 億 (+10.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GHGuardant Health, Inc. | COM | 3,338,241 | $3.08 億 | 6.4% | +538,241+19.2% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 11,526,971 | $2.86 億 | 5.9% | 00.0% | 不變 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 3,600,000 | $2.53 億 | 5.2% | +595,966+19.8% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 4,300,000 | $2.50 億 | 5.2% | +300,000+7.5% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 4,279,848 | $2.06 億 | 4.3% | +168,066+4.1% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 1,100,000 | $1.86 億 | 3.8% | −50,000−4.3% | 減碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 4,532,374 | $1.82 億 | 3.8% | −3,217,626−41.5% | 減碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 19,686,282 | $1.67 億 | 3.4% | +11,615,868+143.9% | 加碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 4,106,067 | $1.65 億 | 3.4% | +1,284,932+45.5% | 加碼 | 歷史 |
| ALMSAlumis Inc. | COM | 6,772,595 | $1.49 億 | 3.1% | +6,772,595 | 新進 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 1,950,000 | $1.46 億 | 3.0% | +250,000+14.7% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 1,376,324 | $1.41 億 | 2.9% | +1,376,324 | 新進 | 歷史 |
| ALKSAlkermes plc. | SHS | 3,590,323 | $1.27 億 | 2.6% | +1,590,323+79.5% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,158,041 | $1.25 億 | 2.6% | +1,158,041+57.9% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 6,408,863 | $1.19 億 | 2.5% | +1,798,792+39.0% | 加碼 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 3,477,562 | $1.04 億 | 2.1% | −768,878−18.1% | 減碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 2,034,203 | $9,978 萬 | 2.1% | −127,307−5.9% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 6,345,244 | $9,835 萬 | 2.0% | −691,211−9.8% | 減碼 | 歷史 |
| GMABGenmab A/S | SPONSORED ADS | 3,663,250 | $9,828 萬 | 2.0% | +3,663,250 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 1,374,320 | $9,058 萬 | 1.9% | −1,962,678−58.8% | 減碼 | 歷史 |
| GRALGRAIL, Inc. | COM | 1,722,797 | $8,903 萬 | 1.8% | +700,000+68.4% | 加碼 | 歷史 |
| LBRXLB Pharmaceuticals Inc | COM SHS | 3,352,804 | $8,268 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 2,757,569 | $8,231 萬 | 1.7% | −492,221−15.1% | 減碼 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 4,062,500 | $8,080 萬 | 1.7% | +1,448,496+55.4% | 加碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 12,161,496 | $6,725 萬 | 1.4% | +4,827,173+65.8% | 加碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 1,150,000 | $6,496 萬 | 1.3% | −1,150,000−50.0% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 841,445 | $6,249 萬 | 1.3% | +31,303+3.9% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 1,931,884 | $5,825 萬 | 1.2% | −72,094−3.6% | 減碼 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 2,750,000 | $5,753 萬 | 1.2% | +295,438+12.0% | 加碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 3,000,000 | $5,670 萬 | 1.2% | +1,323,460+78.9% | 加碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,073,877 | $5,661 萬 | 1.2% | +304,829+39.6% | 加碼 | 歷史 |
| GERNGeron Corp | COM | 31,720,278 | $4,726 萬 | 1.0% | −790,993−2.4% | 減碼 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 600,000 | $4,614 萬 | 1.0% | +122,316+25.6% | 加碼 | 歷史 |
| CRMDCorMedix Inc. | COM | 6,274,076 | $4,260 萬 | 0.9% | +1,000,000+19.0% | 加碼 | 歷史 |
| ATAIAtaiBeckley Inc. | COM SHS | 12,000,000 | $4,248 萬 | 0.9% | +7,322,711+156.6% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,283,979 | $4,073 萬 | 0.8% | −616,759−32.4% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,000,000 | $3,849 萬 | 0.8% | +546,898+120.7% | 加碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 2,491,539 | $3,645 萬 | 0.8% | +2,491,539 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,000,000 | $3,626 萬 | 0.7% | −650,000−24.5% | 減碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 1,078,710 | $3,612 萬 | 0.7% | +78,710+7.9% | 加碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 9,345,000 | $3,504 萬 | 0.7% | +9,345,000 | 新進 | 歷史 |
| MANEVeradermics, Inc | COMMON STOCK | 500,000 | $3,158 萬 | 0.7% | +500,000 | 新進 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 5,740,850 | $3,043 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 4,377,572 | $2,981 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,393,944 | $2,727 萬 | 0.6% | −1,130,889−44.8% | 減碼 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 6,339,535 | $2,618 萬 | 0.5% | +1,325,874+26.4% | 加碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 3,565,062 | $2,567 萬 | 0.5% | +3,565,062 | 新進 | 歷史 |
| ENTAEnanta Pharmaceuticals Inc | COM | 1,956,867 | $2,472 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 285,000 | $2,399 萬 | 0.5% | +285,000 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 2,643,542 | $2,149 萬 | 0.4% | +2,643,542 | 新進 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 9,487,745 | $2,144 萬 | 0.4% | +9,487,745 | 新進 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 820,765 | $1,956 萬 | 0.4% | +820,765 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $1,944 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| PSNLPersonalis, Inc. | COM | 3,000,000 | $1,911 萬 | 0.4% | +3,000,000 | 新進 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,187,290 | $1,650 萬 | 0.3% | +1,097,701+1,225.3% | 加碼 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM SHS | 835,655 | $1,061 萬 | 0.2% | +835,655 | 新進 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 453,686 | $833.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IVAInventiva S.A. | ADS | 1,222,453 | $678.5 萬 | 0.1% | +732,453+149.5% | 加碼 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 1,500,000 | $675.0 萬 | 0.1% | +1,500,000 | 新進 | 歷史 |
| HELPCybin Inc. | COM NEW | 1,313,137 | $630.3 萬 | 0.1% | −541,118−29.2% | 減碼 | 歷史 |
| BLLNBillionToOne, Inc. | CL A | 50,000 | $394.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM NEW | 444,110 | $330.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $12.8 億 | – |
2025 年第 4 季之後清倉（5 檔）
2025 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 4 季股數 | 2025 年第 4 季市值 | 2025 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| DVAXDynavax Technologies Corp | COM NEW | 15,726,349 | $2.42 億 | 5.5% | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 366,435 | $1,642 萬 | 0.4% | 歷史 |
| MNPRMonopar Therapeutics | COM NEW | 95,408 | $623.0 萬 | 0.1% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 110,448 | $374.1 萬 | 0.1% | 歷史 |
| ANLAdlai Nortye Group Ltd. | ADS | 34,852 | $4.95 萬 | <0.1% | 歷史 |